UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018660
Receipt number R000021237
Scientific Title Japanese POEMS syndrome with thalidmaide trial for compassionate use
Date of disclosure of the study information 2015/08/17
Last modified on 2022/01/11 15:30:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Japanese POEMS syndrome with thalidmaide trial for compassionate use

Acronym

Japanese POEMS syndrome with thalidmaide trial for compassionate use (JPOST15)

Scientific Title

Japanese POEMS syndrome with thalidmaide trial for compassionate use

Scientific Title:Acronym

Japanese POEMS syndrome with thalidmaide trial for compassionate use (JPOST15)

Region

Japan


Condition

Condition

Crow-Fukase(POEMS) syndrome

Classification by specialty

Hematology and clinical oncology Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to provide FPF300 in POEMS syndrome for compationate use and to investigate long term safty and efficacy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety:Adverse event during FPF300 treatment
Efficacy:Overall survival

Key secondary outcomes

1.Serum VEGF level
2.Motor function(Manual Muscle Test, grip strength,ONLS)
3.Median nerve conducton study (conduction velocity, CMAP amplitude, F-wave latency, SNAP amplitudes), Sural nerve conduction study (SNAP amlitudes and conduction velocity)
4.M protein (immunofixation)
5. Pleural effusion
6. Body weight


Base

Study type

Interventional


Study design

Basic design

expanded access

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

FPF300 (thalidomide)100-300mg/day,at bedtime +Dexamethasone 20mg/day (day1-4)

Duration:until the approval of thalidomide for POEMT syndrome

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients with Crow-Fukase syndrome (confirmed by diagnostic criteria)
(2) Patients aged 20 and older
(3) Patients without severe liver or renal dysfunction
(4) Patients without clinicaly probrematic ECG findings or severe bradycardia which require treatment.
(5) Patients with written informed consent
(6) Patients with informed consent to thalidomide education and risk management system

Key exclusion criteria

(1) Patients with the complication which leading to a high risk of severe adversed event by thalidomide (Absolute neutrophil count < 1000, Platelet count< 50000, repeated ileus,severe cardiac arrhythmias)
(2) Female patients who are pregnant, desire childbearing or breastfeeding
(3) Males patients who desire fertility.
(4) Patients with severe complicaitons ( cardiac failure, renal failure liver failure, bleeding enterogastric ulcer, ileus, poorly controlled diabetes)
(5) Patients who allergic to thalidomide
(6) Patients with severe phychiatric disorders
(7) Patients who has been participated any other clinical trial
(8)Patients who are not appropriate to participate to the trial

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Satoshi
Middle name
Last name Kuwabara

Organization

Chiba University, Graduate School of Medicine

Division name

Department of Neurology

Zip code

2608677

Address

Inohana 1-8-1, Chuo-ku, Chiba-shi, Chiba 260-8670, Japan

TEL

0432227171

Email

syukari536@chiba-u.jp


Public contact

Name of contact person

1st name Kanako
Middle name
Last name Katayama

Organization

Chiba University Hospital

Division name

Clinical research center

Zip code

2608677

Address

Inohana 1-8-1, Chuo-ku, Chiba-shi, Chiba 260-8670, Japan

TEL

0432227171

Homepage URL


Email

katayama-k@umin.net


Sponsor or person

Institute

Chiba University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Chiba university hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical research center, Chiba university hospital

Address

1-8-1 Inohana Chuo-ku Chiba city

Tel

0432227171

Email

yamazaki@office.chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 06 Month 25 Day

Date of IRB

2015 Year 07 Month 22 Day

Anticipated trial start date

2015 Year 08 Month 17 Day

Last follow-up date

2020 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 08 Month 13 Day

Last modified on

2022 Year 01 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021237


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name